AzTrials
AzTrials

Maxillary DeficiencySINUSLID_2023NCT06222970

Maxillary Sinus Augmentation Via the "Bone Lid Technique"

An observational study of Maxillary Deficiency, run by University of Pisa at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Maxillary sinus augmentation is one of the most performed procedures to increase the bone quantity of the atrophic maxilla in order to allow implant placement. The aim of the present case series was to describe a surgical protocol to perform maxillary sinus augmentation with the "bone lid technique", and its outcomes… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Maxillary Deficiency
What is being tested?
Bone lid repositioning in course of sinus lift
Type of treatment
Surgery or procedure
How many people
40 participants
Where
1 siteItaly
Study dates
4 May 2020to Dec 2024
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: patients referred to the Unit of Dentistry and Oral Surgery, University Hospital of Pisa, with a severe bone atrophy of the maxillary posterior areas that required bone grafting through a lateral approach of the maxillary sinus

Who may be able to join

  • Partially or fully edentulous patients requiring an implant-prosthetic rehabilitation of the premolar or molar maxillary areas with a residual ridge height lower than 4 mm.
  • Patients needing for a unilateral or bilateral sinus lift with a lateral wall approach.

Who cannot join

  • Patients under treatment with immunosuppressive agents
  • Patients under treatment with medications that could impair bone metabolism.
  • Patients pregnant or breastfeeding.
  • Patients who had received irradiation treatment to the head and neck area.
  • Patients with uncontrolled diabetes.
  • Patients with uncontrolled periodontal disease.

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • U.O. Odontostomatologia e Chirurgia del Cavo Orale

    Pisa, 56126

    Antonio Barone, Professor, 050993327, antonio.barone@unipi.it

    Recruiting

Other trials in Italy

About this study

Maxillary sinus augmentation is one of the most performed procedures to increase the bone quantity of the atrophic maxilla in order to allow implant placement. The aim of the present case series was to describe a surgical protocol to perform maxillary sinus augmentation with the "bone lid technique", and its outcomes in a cohort of patients eligible for the procedure.

Being tested
Bone lid repositioning in course of sinus lift
Medical subject headings
Retrognathia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bone lid repositioning in course of sinus liftProcedure or surgery

    A full-thickness flap was elevated to access the lateral maxillary bone wall. Subsequently, a lateral access window was prepared using a piezoelectric device with specific bone tips, delimitating a trapezoidal bone lid.

    Once the antrostomy was completed, the bone lid was gently removed with a Lucas surgical curette and anatomical tweezers, with great care to avoid damages to the Schneiderian membrane. The Schneiderian membrane was detached from the bone layer using specific sinus curettes. In case of sinus membrane perforation, the membrane was raised in all directions. All clinical cases received a cortical bone lamina to avoid graft particles displacement in the maxillary sinus. The elevated space was filled with chips of cortico-spongious bone. The antrostomy was then covered with the bone lid (osteotomy window), previously removed and preserved in physiological solution and fixed in the original anatomical position with a surgical glue. The flap was then repositioned and sutured.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone gain

    Measurement of bone height and width

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2024
  2. Study start4 May 2020
  3. Primary completion18 Sep 2023
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT06222970
Sponsor's protocol ID
SINUSLID_2023
Acronym
SINUSLID_2023
Status last verified
Jan 2024
First submitted
15 Jan 2024
Last updated
30 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: data will be published after anonymization and/or as aggregated data

Questions about this trial

What is this clinical trial studying?

An observational study of Maxillary Deficiency, run by University of Pisa at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone gain (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in